Send mail to Author

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __     ___      _  _     ______   _    _    __   __  
 | |/ //   / _ \\   | \| ||  /_   _// | || | ||  \ \\/ // 
 | ' //   | / \ ||  |  ' ||   -| ||-  | || | ||   \ ` //  
 | . \\   | \_/ ||  | .  ||   _| ||_  | \\_/ ||    | ||   
 |_|\_\\   \___//   |_|\_||  /_____//  \____//     |_||   
 `-` --`   `---`    `-` -`   `-----`    `---`      `-`'
 


Back to frontdoor view

OPUS4 Logo